Delivery Order SPE2DB22D2103-SPE2DB23FR8VM
Award Date 3/6/23
Potential Completion Date 3/7/23
Potential Value $90K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,820.34 firm fixed-price delivery order covers the supply of Plaquenil 200 mg tablets to support federal healthcare programs, with a completion date of September 2, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.48 firm fixed price Delivery Order (SPE2DB23FN7U6) is for the supply of 4,561,315,651 Plaquenil 200 mg tablets, with a completion date of June 23, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (SPE2DB20D3103) with the DLA Troop Support Medical, which...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,922.65 for the supply of Plaquenil 200 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 23, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $20,519.19 firm-fixed-price delivery order is for the supply of Plaquenil 200 mg tablets to DLA Troop Support Medical, which provides pharmaceuticals and medical supplies to military treatment programs and facilities. Amerisourcebergen Drug Corp also holds a separate indefinite delivery contract (IDC) with DLA, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Plaquenil 200 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,811.08 and a performance period through July 26, 2023. The award is not subject to any set-aside requirements. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $96,056.33, is for the delivery of 100 bottles of Plaquenil 200 mg tablets. The contract has a completion date of March 9, 2023 and is a firm fixed-price delivery order. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor...
- This federal contract award, with the ID SPE2DB20D3101|SPE2DB22FJ6A5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,525.27 firm-fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used for the treatment of malaria, lupus, and certain types of arthritis. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,026.35, is for the delivery of Plaquenil 200 mg tablets over the period ending November 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide PLAQUENIL 200 MG TABLET 100S. The award has a ceiling value of $2,191.75 and is a Firm Fixed Price Delivery Order contract that runs through April 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...